Observational study of corrected count increments after transfusion of platelets treated with riboflavin pathogen reduction technology in additive solutions

Publisher： John Wiley & Sons Inc

E-ISSN： 1537-2995|55|7|1745-1751

ISSN： 0041-1132

Source： TRANSFUSION, Vol.55, Iss.7, 2015-07, pp. : 1745-1751

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

The impact of platelet additive solution apheresis platelets on allergic transfusion reactions and corrected count increment (CME)

By  

TRANSFUSION, Vol. 54, Iss. 6, 2014-06 ,pp. : 1523-1529

John Wiley & Sons Inc

Access to resources Recommend Favorite

Pathogen Reduction Technology Treatment of Platelets, Plasma and Whole Blood Using Riboflavin and UV Light

By  

Transfusion Medicine and Hemotherapy, Vol. 38, Iss. 1, 2011-01 ,pp. : 8-18

Karger

Access to resources Recommend Favorite

Treatment of Buffy Coat Platelets in Platelet Additive Solution with the Mirasol® Pathogen Reduction Technology System

By  

Transfusion Medicine and Hemotherapy, Vol. 40, Iss. 1, 2013-01 ,pp. : 44-48

Karger

Access to resources Recommend Favorite

Evaluation of Different Preparation Procedures of Pathogen Reduction Technology(Mirasol®)-Treated Platelets Collected by Plateletpheresis

By  

Transfusion Medicine and Hemotherapy, Vol. 36, Iss. 5, 2009-08 ,pp. : 309-315

Karger

Access to resources Recommend Favorite

A randomized noninferiority crossover trial of corrected count increments and bleeding in thrombocytopenic hematology patients receiving 2‐ to 5‐ versus 6‐ or 7‐day–stored platelets

By  

TRANSFUSION, Vol. 55, Iss. 8, 2015-08 ,pp. : 1856-1865

John Wiley & Sons Inc

Access to resources Recommend Favorite